|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 March 2021 |
|
Main ID: |
NCT03402412 |
|
Date of registration:
|
10/01/2018 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Atopic Dermatitis: Early Gene Expression Changes as Predictors of Therapeutic Response to Narrow-band UVB Treatment
|
|
Scientific title:
|
Atopic Dermatitis: Early Gene Expression Changes as Predictors of Therapeutic Response to Narrow-band UVB Treatment |
|
Date of first enrolment:
|
September 19, 2017 |
|
Target sample size:
|
16 |
|
Recruitment status: |
Active, not recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03402412 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Norway
| | | | | | | |
|
Contacts
|
|
Name:
|
Jan-Oivind Holm, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Oslo University Hospital/University of Oslo |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Atopic dermatitis
Exclusion Criteria:
- Other inflammatory skin disease
- Concurrent illness
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Atopic Dermatitis
|
|
Intervention(s)
|
|
Other: narrow-band UVB
|
|
Primary Outcome(s)
|
|
Early gene expression changes in atopic skin after UVB-treatment
[Time Frame: Study period for each participant: 9 weeks]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|